5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
Condition: Oligometastatic Prostate Cancer Interventions: Radiation: Hypofractionated external beam radiotherapy; Radiation: High dose rate brachytherapy; Radiation: Permanent seed implant; Radiation: Stereotactic body radiotherapy Sponsor: British Columbia Cancer Agency Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Prostate Cancer | Research